Detalles de la búsqueda
1.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906039
2.
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance.
Eur Urol
; 85(2): 154-163, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714742
3.
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study.
Prostate Int
; 12(1): 20-26, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523897
4.
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study.
Cancer Res Commun
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669053
5.
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
Eur Urol
; 83(4): 320-328, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35654659
Resultados
1 -
5
de 5
1
Próxima >
>>